Thursday, July 30, 2020

Biocon Biologics valued at $3.5 billion after Tata Capital's $30 million financing

Through investments in R&D and high-quality manufacturing infrastructure, we are confident of achieving our aspiration of serving 5 million patients through our biosimilars portfolio, CEO Hamachar said https://ift.tt/33dByn4 https://ift.tt/eA8V8J

No comments:

Post a Comment

The EU Commission charges Temu with failing to cooperate during a December 2025 raid on its Dublin HQ as part of a probe into the company's foreign subsidies (Inti Landauro/Reuters)

Inti Landauro / Reuters : The EU Commission charges Temu with failing to cooperate during a December 2025 raid on its Dublin HQ as part o...